Florian Naudet
Meta-researcher, Clinician, Professor at Rennes University, Senior member at Institut Universitaire de France, affiliate at METRICStanford. ORCID: 0000-0003-3760-3801
Posts are my own.
Website: restores.univ-rennes.fr
- New post on ResToRes' website: "Pay-to-publish proposals persist: a third email emerges" Sorry for the repetition in the topic of my posts, but I’m increasingly concerned by the emails I’ve started receiving as an editor. I’ve received three so far this year. restores.univ-rennes.fr/highlights/p...
- In @jclinepi.bsky.social : « There Is No Upper Limit on the Maximum Effect That Can Be Detected in Randomized Trials »
- "French trial sponsors are urged to bolster clinical trial transparency": STAT News covers the recent French report urging that study results be published in a registry. I was very happy to be interviewed and provide some context.
- @sharectd.bsky.social might be of interest
- New post on ResToRes's website : "Transparency, at last: France’s call to open up clinical trials" France takes long-awaited steps to ensure clinical trial transparency. New national report calls for mandatory result posting and cultural change. restores.univ-rennes.fr/highlights/t...
- 🇫🇷 "Ensuring that the results of all clinical trials in France are posted" Report submitted to the Open Science Steering Committee set up on 16 May 2024 "It is our collective responsibility to post all clinical trial results in a timely fashion." www.enseignementsup-recherche.gouv.fr/sites/defaul...
- New post on ResToRes's website "Massive collaboration sharpens tools for identifying problematic trials". It is about the recent publication of INSPECT-SR Stage 2 findings in The Journal of Clinical Epidemiology. restores.univ-rennes.fr/highlights/m...
- New post on ResToRes' website about a 👍 study @plosbiology.org. "Inappropriate study designs and false discoveries: how paper mills may be exploiting NHANES" NHANES is a widely accessible dataset, supporting open science but also raising concerns when misused. restores.univ-rennes.fr/highlights/i...
- @sharectd.bsky.social might be of great interest.
- From 2015 to 2023, eight years of empirical research on research integrity: a scoping review
- Everything is possible—even the improbable: Vinay Prasad at the FDA and a Bayesian Pope. I don’t know which surprises me more. Wishing them the best of luck. Meanwhile, pass the popcorn.
- Well, probably just a namesake… but I haven’t lost hope he’s Bayesian too.
- 🚨📢 Postdoc opening @EMORY EPIDEMIOLOGY with the stellar JOSHUA WALLACH in pharmaceutical regulation, evidence synthesis & meta-research. 1-year position w/ possible renewal. Formal posting coming soon—message or email JOSH for details. Please share!
- "From peer review to pay review" new post on ResToRes's website. We previously highlighted an email from a suspected papermill offering payment to an editor for article publication. We share a new message from another likely papermill making a similar offer. restores.univ-rennes.fr/highlights/p...
- Biases and debiasing in policy decision-making onlinelibrary.wiley.com/doi/full/10....
- In partnership with RestoRes and Embrace, LORIER’s monthly webinars address key issues for reproducible health research, including data sharing, reproducibility, and meta-research. This series, starting in June 2025, features international experts. restores.univ-rennes.fr/highlights/l...
- And please note that folks that have registered on the OSIRIS network will be invited as soon as we have created a mailing list to facilitate communication. Hopefully, early next week.
- This is indeed also in partnership with OSIRIS, @sharectd.bsky.social and @reproductible-fr.bsky.social.
- "This cross-sectional study of high-risk therapeutic medical device approvals from 2019 through 2023 found that 51% were based on primary safety or effectiveness analyses that used nonconcurrent, as opposed to concurrent, controls."
- A study, a strobe light, and a lab that’s actually someone’s living room—what could possibly go wrong? Award-winning science, unreplicated results, and a flicker of controversy... Read our new post on ResToRes' website. restores.univ-rennes.fr/highlights/f...
- I remember discussing here with advocates of lecanemab. Sobering letter from members of EMA scientific advisory group. www.bmj.com/content/389/...
- New post on the ResToRes' website: COPE's latest statement underscores the critical importance of editorial independence, warning against undue external influences that threaten the integrity of scholarly publishing. restores.univ-rennes.fr/highlights/c...
- New post on ResToRes' website. In a rapid response to the recent VITALITY Study 1, we highlight the persistent contamination of healthcare evidence not only by retracted trials but also by unretracted, flawed studies—so-called zombie clinical trials. restores.univ-rennes.fr/highlights/m...
- New post on ResToRes' website: "The artemisia debate returns, fueled by a @lemonde.fr Op-Ed". A recent @lemonde.fr op-ed praising Artemisia as a malaria treatment overlooks a darker story of questionable research and ignored warnings. restores.univ-rennes.fr/highlights/a...
- New news story on website. "Zombie trials don't just die after retraction—they continue to pollute meta-analyses, shift effect sizes, and distort clinical guidelines. A new @bmj.com study reveals the measurable scale of this hidden contamination." restores.univ-rennes.fr/highlights/q...
- New news story on ResToRes website, "Rethinking "interests": an historical perspective", covering a very interesting paper. restores.univ-rennes.fr/highlights/r...
- Hello @reproductible-fr.bsky.social. You have just been added to the the meta-research and open science starting pack 2. go.bsky.app/DWo6RbAat://did:plc:3nuyftkga5q32inooxbbxa74/app.bsky.graph.starterpack/3lbozhq3zmz2f
- 🔦 Super happy to highlight a great event by the French Reproducible Research Network! 🎥 Recordings, 🖥️ slides & 📝 notes of the 2025 meeting are now online (in French)! 🔗 www.canal-u.tv/chaines/rfrr... #Reproducibility #OpenScience #MetaResearch #RestoRes
- « This study found limited Patient and Public Involvement reported in randomised controlled trials published in major medical journals and in their respective protocols, underscoring the need for consistent, detailed, and transparent PPI reporting practices in clinical research. »
- "Despite studies investigating a range of interventions and addressing various outcomes, our findings indicate that in general the evidence base for which various interventions to improve reproducibility of research remains remarkably limited in many respects." By OSIRIS
- Estimating the replicability of Brazilian biomedical science
- Nice read by Kelly Cobey. @marind.bsky.social might be interested. blog.cdnsciencepub.com/concerns-abo...
- Researchers are often targeted by solicitations from predatory journals. Two recent emails highlight the pressure exerted by these unscrupulous publishers: "Our editors and reviewers have high standards" [when it comes to harassing you]. On RestoRes's site: restores.univ-rennes.fr/highlights/o...
- Accounting for cross-registration in monitoring responsible research in clinical trials: A cross-sectional study of trials at German university medical centers
- Super cool to be in Lyon for The French Reproducible Research Network meeting. A lots of great talks and a lively community.
- + my slides here: restores.univ-rennes.fr/training-mat...
- Welcome @giulia-varvar.bsky.social, happy to see you here, please note that I need a profile with an image to add you in the meta-research and open science starting pack.
-
View full threadAnd feel free to explore the 1st one...at://did:plc:3nuyftkga5q32inooxbbxa74/app.bsky.graph.starterpack/3lbifmgiuiy2p
- Looking forward to see more @sharectd.bsky.social people here :)
- Hi @giulia-varvar.bsky.social you are now part of the meta-resarch open science starting pack 2. Welcome. go.bsky.app/DWo6RbAat://did:plc:3nuyftkga5q32inooxbbxa74/app.bsky.graph.starterpack/3lbozhq3zmz2f
- New research in JAMA Internal Medicine reveals how much retracted studies skew results in meta-analyses, with sometimes significant changes in effect estimates once these studies are excluded. By @isabelleboutron.bsky.social @gcabanac.cpesr.fr et al. jamanetwork.com/journals/jam...
